Long-term Effects of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) on Patient-Reported Outcomes and Health-care Utilization in African-American Patients With Asthma

Dose Inhaler ◽

Care Utilization ◽

Metered Dose Inhaler ◽

Long Term Effects ◽

Patient Reported ◽

Metered Dose

Long-term Effects of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in African-American Patients With Moderate to Severe Asthma: Responder Analysis in Patients With Versus Without Fixed Airflow Obstruction (FAO)

CHEST Journal ◽

10.1378/chest.1703057 ◽

2013 ◽

Vol 144 (4) ◽

pp. 83A

Author(s):

Bradley Chipps ◽

Donald P Tashkin ◽

Randall Brown ◽

Tom Uryniak ◽

Frank Trudo

Keyword(s):

African American ◽

Severe Asthma ◽

Airflow Obstruction ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Long Term Effects ◽

Responder Analysis ◽

Metered Dose ◽

Fixed Airflow Obstruction

Evaluation Of Long-Term Cardiovascular Safety, Based On Electrocardiographic Monitoring, Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Predominantly White And Self-Reported African-American Populations With Moderate To Severe Asthma

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4238 ◽

2012 ◽

Author(s):

Randall W. Brown ◽

Christopher D. O'Brien ◽

Ubaldo J. Martin ◽

Tom Uryniak ◽

Kathy L. Lampl

Keyword(s):

African American ◽

Predominantly White ◽

Severe Asthma ◽

Dose Inhaler ◽

Cardiovascular Safety ◽

Metered Dose Inhaler ◽

Electrocardiographic Monitoring ◽

Metered Dose ◽

Long-term Cardiovascular Safety, as Evaluated by Electrocardiographic Monitoring, of Budesonide/Formoterol Pressurized Metered-Dose Inhaler in African-American Patients With Moderate to Severe Asthma

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2011.12.608 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB76

Author(s):

R.W. Brown ◽

C.D. O'Brien ◽

U.J. Martin ◽

T. Uryniak ◽

K.L. Lampl

Keyword(s):

African American ◽

Severe Asthma ◽

Dose Inhaler ◽

Cardiovascular Safety ◽

Metered Dose Inhaler ◽

Electrocardiographic Monitoring ◽

Metered Dose ◽

Effects Of Long-Term Treatment With Budesonide/Formoterol (BUD/FM) Delivered By Pressurized Metered-Dose Inhaler (pMDI) On Symptoms In African-American and Caucasian Patients With Moderate To Severe Asthma With and Without Fixed Airway Obstruction (FAO)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.031 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB2

Author(s):

Randall Brown ◽

Bradley E. Chipps ◽

Donald P. Tashkin ◽

Frank Trudo

Keyword(s):

African American ◽

Airway Obstruction ◽

Severe Asthma ◽

Term Treatment ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Long Term Treatment ◽

Metered Dose ◽

Caucasian Patients

Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

Patient Related Outcome Measures ◽

10.2147/prom.s16159 ◽

2011 ◽

pp. 41 ◽

Cited By ~ 1

Author(s):

R D O'Connor

Keyword(s):

Dose Inhaler ◽

Metered Dose Inhaler ◽

Patient Reported ◽

Metered Dose ◽

Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma

Journal of Asthma ◽

10.3109/02770900903497154 ◽

2010 ◽

Vol 47 (2) ◽

pp. 217-223 ◽

Cited By ~ 10

Author(s):

Richard D. O'Connor ◽

Donald L. Patrick ◽

Bhash Parasuraman ◽

Paula Martin ◽

Mitchell Goldman

Keyword(s):

Fluticasone Propionate ◽

Dry Powder Inhaler ◽

Fixed Dose ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Dry Powder ◽

Patient Reported ◽

Metered Dose ◽

Differential Long-Term Pulmonary Function Outcomes Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler PMDI And Budesonide PMDI In African-American Patients With Asthma

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1293 ◽

2011 ◽

Author(s):

Randall W. Brown ◽

Tom Uryniak ◽

Kathy L Lampl

Keyword(s):

African American ◽

Pulmonary Function ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Metered Dose ◽

Long-term Effects of Budesonide/Formoterol Pressurized Metered-Dose Inhaler on Chronic Obstructive Pulmonary Disease (COPD) Symptoms and Health Status in Patients With COPD

CHEST Journal ◽

10.1378/chest.1114126 ◽

2011 ◽

Vol 140 (4) ◽

pp. 528A ◽

Cited By ~ 2

Author(s):

Amir Sharafkhaneh ◽

Tom Uryniak ◽

Ubaldo Martin

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Health Status ◽

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Long Term Effects ◽

Obstructive Pulmonary Disease ◽

Metered Dose

Long-Term Safety Of Budesonide/formoterol Pressurized Metered-Dose Inhaler (PMDI) And Budesonide PMDI In African-American Patients With Asthma: Asthma Exacerbations And Adverse Events

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294 ◽

2011 ◽

Cited By ~ 1

Author(s):

Randall W. Brown ◽

Tom Uryniak ◽

Kathy L Lampl

Keyword(s):

African American ◽

Adverse Events ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Asthma Exacerbations ◽

Metered Dose ◽

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s171835 ◽

2018 ◽

Vol Volume 13 ◽

pp. 2969-2984 ◽

Cited By ~ 17

Author(s):

Brian J Lipworth ◽

David J Collier ◽

Yasuhiro Gon ◽

Nanshan Zhong ◽

Koichi Nishi ◽

...

Keyword(s):

Phase Iii ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Patient Reported ◽

Metered Dose ◽

The Usa ◽

Phase Iii Study ◽

Delivery Technology ◽

Formoterol Fumarate